SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-060717
Filing Date
2007-08-09
Accepted
2007-08-09 13:43:14
Documents
9
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-18860_110q.htm 10-Q 783844
2 EX-10.5 a07-18860_1ex10d5.htm EX-10.5 25693
3 EX-10.6 a07-18860_1ex10d6.htm EX-10.6 24090
4 EX-10.22 a07-18860_1ex10d22.htm EX-10.22 72445
5 EX-10.23 a07-18860_1ex10d23.htm EX-10.23 90845
6 EX-31.1 a07-18860_1ex31d1.htm EX-31.1 9854
7 EX-31.2 a07-18860_1ex31d2.htm EX-31.2 10373
8 EX-32.1 a07-18860_1ex32d1.htm EX-32.1 4057
9 EX-32.2 a07-18860_1ex32d2.htm EX-32.2 4019
  Complete submission text file 0001104659-07-060717.txt   1026771
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 071039236
SIC: 2835 In Vitro & In Vivo Diagnostic Substances